National

Russian general accused Ukraine of using chemical weapons

Nov 30, 2023

Moscow [Russia], November 30: Commander of the Nuclear, Chemical and Biological Protection Forces of the Russian Armed Forces, Lieutenant General Igor Kirillov, on November 28 alleged that since the outbreak of the Russia-Ukraine conflict on February 24, 2022, the military The Ukrainian team used chemicals to poison food 17 times, causing at least 15 deaths, according to RT.
Mr. Kirillov confirmed that many officials in Russian-controlled areas in Ukraine were poisoned.
General Kirillov also said that there was a risk that the Ukrainian army could start using biological weapons after "failing to achieve any important successes" in their months-long counteroffensive. As of last night, there was no information about Ukraine's reaction to the accusations from General Kirillov. Previously, Mr. OleksandrTarnavskyi, Commander of Ukraine's Tavria combat group, in August accused Russia of continuing to use chemical weapons in Ukraine, according to The Kyiv Independent.
Regarding the war situation, the Russian Ministry of Defense announced on November 29 that a corvette belonging to the country's Black Sea Fleet launched four Kalibr cruise missiles targeting facilities belonging to the Ukrainian armed forces, according to TASS News Agency. . The Russian Ministry of Defense confirmed that the missiles hit the intended targets, but did not specify when the attack took place. The Russian Ministry of Defense also announced that air defense forces shot down a Ukrainian unmanned aerial vehicle (UAV) near Moscow early on the morning of November 29.
Meanwhile, the Ukrainian Air Force said on November 29 that Russia launched 21 UAVs and 3 cruise missiles into Ukraine on the night of November 28-29, but all UAVs and 2 missiles were destroyed before reaching the target, according to Reuters. The Ukrainian Air Force also said that the third missile was not destroyed but did not reach the target.
Source: ThanhNien Newspaper

More news

Concept Medical Announces Successful SIRONA Trial Results, Demonstrating Sirolimus-Coated Balloon as a Promising Alternative for PAD Treatment

Tampa (Florida) [US], January 7: Concept Medical Inc., a global leader in innovative drug-delivery technology, proudly reports positive outcomes from the SIRONA (Head-to-Head Comparison of SIROlimus versus Paclitaxel Drug-Eluting BallooNAngioplasty in the Femoropopliteal Artery) RCT, which show that its sirolimus-coated balloons (SCB) (MagicTouch -PTA) provide patency and functional benefits on par with paclitaxel-coated balloons for patients suffering from peripheral artery disease (PAD). The 1-year data was presented by Principal Investigator Prof. Ulf Teichgraber at the TCT USA 2024 conference in a Late-Breaking Clinical Trials Session (LBCT). Coverage by TCTMD has highlighted these findings, underscoring sirolimus-based therapy as a viable new option in femoropopliteal interventions.

Jan 07, 2025